AU2002368326A1 - Hormone replacement therapy with drospirenone - Google Patents

Hormone replacement therapy with drospirenone

Info

Publication number
AU2002368326A1
AU2002368326A1 AU2002368326A AU2002368326A AU2002368326A1 AU 2002368326 A1 AU2002368326 A1 AU 2002368326A1 AU 2002368326 A AU2002368326 A AU 2002368326A AU 2002368326 A AU2002368326 A AU 2002368326A AU 2002368326 A1 AU2002368326 A1 AU 2002368326A1
Authority
AU
Australia
Prior art keywords
drospirenone
replacement therapy
hormone replacement
hormone
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002368326A
Inventor
Siegfried Meyerhofer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU2002368326A1 publication Critical patent/AU2002368326A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002368326A 2002-11-05 2002-11-05 Hormone replacement therapy with drospirenone Abandoned AU2002368326A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2002/004628 WO2004041288A1 (en) 2002-11-05 2002-11-05 Hormone replacement therapy with drospirenone

Publications (1)

Publication Number Publication Date
AU2002368326A1 true AU2002368326A1 (en) 2004-06-07

Family

ID=32310068

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002368326A Abandoned AU2002368326A1 (en) 2002-11-05 2002-11-05 Hormone replacement therapy with drospirenone

Country Status (2)

Country Link
AU (1) AU2002368326A1 (en)
WO (1) WO2004041288A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005056527A1 (en) * 2005-11-25 2007-07-12 Grünenthal GmbH Use of a combination of ethinylestradiol and chlormadinone acetate for the manufacture of a medicament
BR112012026115B1 (en) 2010-04-15 2019-12-24 Bayer Ip Gmbh solid oral dosage form, its use, and packaging unit
DE102011012712A1 (en) * 2011-03-01 2012-09-06 Frank Lehmann-Horn Use of aldosterone receptor antagonists for the treatment of female sexual dysfunction

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083528A (en) * 1995-09-28 2000-07-04 Schering Aktiengesellschaft Hormone replacement therapy method and hormone dispenser
UA74141C2 (en) * 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Oral pharmaceutical compositions comprising micronized eplerenone (variants), method for its production and method for treating aldosterone-mediated states (variants)
JP2002533411A (en) * 1998-12-23 2002-10-08 ジー．ディー．サール エルエルシー Combinations for applying to cardiovascular
CN101934078A (en) * 2000-01-18 2011-01-05 拜耳先灵医药股份有限公司 Pharmaceutical composition comprising drospirenone and estrogen, and application thereof
CA2416152A1 (en) * 2000-07-27 2002-02-07 Pharmacia Corporation Aldosterone blocker therapy to prevent or treat inflammation-related disorders
EP1313485B1 (en) * 2000-08-28 2005-10-12 Pharmacia Corporation Use of an aldosterone receptor antagonist to improve cognitive function
DE10100911A1 (en) * 2001-01-11 2002-08-01 Schering Ag Process for hormone replacement therapy and its dosage form

Also Published As

Publication number Publication date
WO2004041288A1 (en) 2004-05-21

Similar Documents

Publication Publication Date Title
AU2003288586A1 (en) Electrode arrangement
AU2003288959A1 (en) Body region indication
AU2003260760A1 (en) Implantable replacement joint
EP1578782A3 (en) Combination therapy with co-stimulatory factors
AU2003296895A1 (en) Combination therapy for controlling appetites
ZA200308027B (en) Hormone replacement therapy
AU2003209226A1 (en) Adiponectin gene therapy
AU2003220410A1 (en) Airway assembly
AU2003203099A1 (en) Manually-propelled wheelchair
AU2002313298A1 (en) Body reinforcing material arrangement structure
AU2003259457A1 (en) Auto-destructible syringe
AU2003247005A1 (en) Therapy combination
AU2003293253A1 (en) Selecting electrotherapy dosage
AU2003245794A1 (en) Glycosaminoglycan-dnase combination therapy
AU2003228198A1 (en) Av-fistula bandage
AU2003206730A1 (en) Fitting
AU2003215150A1 (en) Therapeutic compounds
AU2003297657A1 (en) Antifungal therapeutic agents
AU2002368326A1 (en) Hormone replacement therapy with drospirenone
AU2003213956A1 (en) Improved hormone replacement therapy
AU2003255727A1 (en) Syringes
AU2002952559A0 (en) New use
AU2003285079A1 (en) Neurostimulation therapy manipulation
AU2003211523A1 (en) Electrode structural body
AU2003243360A1 (en) Polyamine-mediated transfection

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase